Oncología Traslacional
ONCTRAS
José Javier
Aristu Mendioroz
Consultor Médico
Publications by the researcher in collaboration with José Javier Aristu Mendioroz (48)
2022
2021
-
Intraoperative electron beam radiotherapy and perioperative high-dose-rate brachytherapy in previously irradiated oligorecurrent gynecological cancer: clinical outcome analysis
Clinical and Translational Oncology, Vol. 23, Núm. 9, pp. 1934-1941
2019
-
A novel concept to include uncertainties in the evaluation of stereotactic body radiation therapy after 4D dose accumulation using deformable image registration
Medical Physics, Vol. 46, Núm. 10, pp. 4346-4355
-
Erratum: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience (PLoS ONE (2019)14:6 (e0217881)Doi:10.1371/journal.pone.0217881)
PLoS ONE
-
Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience
PLoS ONE, Vol. 14, Núm. 6
-
Long-term results of Perioperative High Dose Rate Brachytherapy (PHDRB) and external beam radiation in adult patients with soft tissue sarcomas of the extremities and the superficial trunk: Final results of a prospective controlled study
Radiotherapy and Oncology, Vol. 135, pp. 91-99
2016
-
Dose escalation with external beam radiation therapy and high-dose-rate brachytherapy combined with long-term androgen deprivation therapy in high and very high risk prostate cancer: Comparison of two consecutive high-dose-rate schemes
Brachytherapy, Vol. 15, Núm. 2, pp. 127-135
-
Multicatheter breast implant during breast conservative surgery: Novel approach to deliver accelerated partial breast irradiation
Brachytherapy, Vol. 15, Núm. 4, pp. 485-494
-
Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients
Clinical and Translational Oncology, Vol. 18, Núm. 3, pp. 259-268
2015
-
Pneumomediastinum as a complication of SABR for lung metastases
Radiation Oncology, Vol. 10, Núm. 1
-
Salvage surgery and radiotherapy including intraoperative electron radiotherapy in isolated locally recurrent tumors: Predictors of outcome
Radiotherapy and Oncology, Vol. 116, Núm. 2, pp. 316-322
-
Salvage wide resection with intraoperative electron beam therapy or HDR brachytherapy in the management of isolated local recurrences of soft tissue sarcomas of the extremities and the superficial trunk
Brachytherapy, Vol. 14, Núm. 1, pp. 62-70
2012
-
External-beam radiation therapy and high-dose rate brachytherapy combined with long-term androgen deprivation therapy in high and very high prostate cancer: Preliminary data on clinical outcome
International Journal of Radiation Oncology Biology Physics, Vol. 82, Núm. 3
-
Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial
International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593
-
Pathological vertebral fracture after stereotactic body radiation therapy for lung metastases. Case report and literature review
Radiation Oncology, Vol. 7, Núm. 1
-
The multimodal management of locally advanced N2 non-small cell lung cancer: Is there a role for surgical resection? A single institution's experience
Clinical and Translational Oncology, Vol. 14, Núm. 11, pp. 835-841
2011
-
Patterns of response after preoperative intensity-modulated radiation therapy and capecitabine/oxaliplatin in rectal cancer: Is there still a place for ecoendoscopic ultrasound?
International Journal of Radiation Oncology Biology Physics, Vol. 81, Núm. 2, pp. 439-444
2010
-
A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer
International Journal of Gynecological Cancer, Vol. 20, Núm. 1, pp. 133-140
-
Concomitant cisplatin, paclitaxel, and hyperfractionated radiotherapy in locally advanced head and neck cancer: Comparison of two different schedules
American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 33, Núm. 2, pp. 137-143